Credit Suisse Sees Downside In Shares Of Salix Pharmaceuticals, Ltd.
September 12, 2014 at 11:28 AM EDT
Analysts at Credit Suisse initiated coverage on Salix Pharmaceuticals, Ltd. (NASDAQ: SLXP) with an Underperform rating and $139 price ...